Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for MDxHealth (MDXH) over the last 5 years, with Dec 2024 value amounting to -$1.16.

  • MDxHealth's EPS (Weighted Average and Diluted) fell 1.99% to $154,279 in Q3 2025 from the same period last year, while for Sep 2025 it was $627,074, marking a year-over-year increase of 16.31%. This contributed to the annual value of -$1.16 for FY2024, which is 30.12% up from last year.
  • According to the latest figures from FY2024, MDxHealth's EPS (Weighted Average and Diluted) is -$1.16, which was up 30.12% from -$1.66 recorded in FY2023.
  • Over the past 5 years, MDxHealth's EPS (Weighted Average and Diluted) peaked at $75,072 during FY2021, and registered a low of -$2.78 during FY2022.
  • In the last 3 years, MDxHealth's EPS (Weighted Average and Diluted) had a median value of -$1.66 in 2023 and averaged -$1.87.
  • In the last 5 years, MDxHealth's EPS (Weighted Average and Diluted) skyrocketed by 135.66% in 2021 and then tumbled by 100.00% in 2022.
  • MDxHealth's EPS (Weighted Average and Diluted) (MRY) stood at $31,856 in 2020, then surged by 135.66% to $75,072 in 2021, then plummeted by 100.00% to -$2.78 in 2022, then soared by 40.29% to -$1.66 in 2023, then skyrocketed by 30.12% to -$1.16 in 2024.
  • Its EPS (Weighted Average and Diluted) was -$1.16 in FY2024, compared to -$1.66 in FY2023 and -$2.78 in FY2022.